FindTrial
Sign In

Efficacy of a single intravenous venous dose of parecoxib 40 mg for post-operative pain control after elective cesarean delivery: a double blind randomized controlled trial

The study aims to investigate the effectiveness of parecoxib 40 mg in controlling pain after elective cesarean delivery. The subjects were divided into 2 groups: intervention and control group. The intervention includes pregnant women who age over 20

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20140909001
Enrollment
82
Registered
2014-09-09
Start date
2014-09-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum women Elective cesarean delivery Parecoxib cesarean delivery

Interventions

Parecoxib 40 mg (2 mL) IV within 2 hours after elective cesarean delivery,0.9% NSS 2 mL within 2 hours after elective cesarean delivery
Experimental Drug,Placebo Comparator Drug
Parecoxib,Normal saline

Sponsors

Faculty of Medicine. Siriraj Hospital. Mahidol University
Lead Sponsor
The Siriraj Routine to Research Unit
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women age over 20 years old Admission of elective cesarean delivery Anesthetic method is spinal anesthesia

Exclusion criteria

Exclusion criteria: Contraindication to NSAIDs Allergy to NSAIDs Current medication is warfarin and antifungal drugs

Design outcomes

Primary

MeasureTime frame
morphine and its derivatives 24 hours after intervention cumulative doses in mg—

Secondary

MeasureTime frame
pain 24 hours after intervention numeric pain score,Cost 24 hours after intervention total cost of pain control—

Countries

Thailand

Contacts

Public ContactTripop Lertbunnaphong

Faculty of Medicine, Siriraj Hospital, Mahidol University

tripop2520@hotmail.com+66818749282

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026